BE845613A - Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone - Google Patents

Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone

Info

Publication number
BE845613A
BE845613A BE170156A BE170156A BE845613A BE 845613 A BE845613 A BE 845613A BE 170156 A BE170156 A BE 170156A BE 170156 A BE170156 A BE 170156A BE 845613 A BE845613 A BE 845613A
Authority
BE
Belgium
Prior art keywords
17beta
nandrolone
esters
new
oral administration
Prior art date
Application number
BE170156A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE845613A publication Critical patent/BE845613A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BE170156A 1975-08-27 1976-08-27 Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone BE845613A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7510104A NL7510104A (nl) 1975-08-27 1975-08-27 Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.

Publications (1)

Publication Number Publication Date
BE845613A true BE845613A (fr) 1977-02-28

Family

ID=19824362

Family Applications (1)

Application Number Title Priority Date Filing Date
BE170156A BE845613A (fr) 1975-08-27 1976-08-27 Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone

Country Status (17)

Country Link
US (1) US4083973A (el)
JP (1) JPS5231063A (el)
AU (1) AU508727B2 (el)
BE (1) BE845613A (el)
CA (1) CA1092025A (el)
DE (1) DE2638507A1 (el)
FR (1) FR2321892A1 (el)
GB (1) GB1563302A (el)
GR (1) GR70296B (el)
HU (1) HU176743B (el)
IE (1) IE44533B1 (el)
IL (1) IL50274A (el)
LU (1) LU75648A1 (el)
NL (1) NL7510104A (el)
NZ (1) NZ181865A (el)
PH (1) PH12363A (el)
ZA (1) ZA764868B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
FR2427100A1 (fr) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
US5208032A (en) * 1988-07-15 1993-05-04 Rutgers, The State University Of New Jersey Increasing the growth of turkeys using implant of 19-nortestosterone
ATE333867T1 (de) * 1994-03-18 2006-08-15 Shire Lab Inc Emulgierte arzneistoffabgabesysteme
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US6011027A (en) * 1999-02-18 2000-01-04 Lpj Research, Inc. Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
JP4995407B2 (ja) 2002-04-25 2012-08-08 バナー ファーマキャップス， インコーポレーテッド 咀嚼可能なソフトカプセル
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
EP1530965B1 (en) 2003-11-11 2006-03-08 Mattern, Udo Controlled release delivery system of sexual hormones for nasal application
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
AU2006299833B2 (en) 2005-10-12 2012-04-12 Besins Healthcare Luxembourg Sarl Improved testosterone gel and method of use
MX2009003654A (es) 2006-10-04 2009-04-22 M & P Patent Ag Sistema de suministro por liberacion controlada para la aplicacion nasal de neurotransmisores.
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
CA2950670A1 (en) 2014-06-17 2015-12-23 Merck Sharp & Dohme B.V. Stable formulations of testosterone undecanoate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998423A (en) * 1958-02-25 1961-08-29 Organon Esters of 19-nortestosterone
US3016388A (en) * 1959-06-30 1962-01-09 Organon New esters of 19-nor-testosterone
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
IL50274A (en) 1980-11-30
FR2321892A1 (fr) 1977-03-25
CA1092025A (en) 1980-12-23
DE2638507A1 (de) 1977-03-03
IE44533B1 (en) 1981-12-30
LU75648A1 (el) 1977-03-31
HU176743B (en) 1981-05-28
IL50274A0 (en) 1976-10-31
AU508727B2 (en) 1980-04-03
FR2321892B1 (el) 1979-05-25
AU1698076A (en) 1978-02-23
JPS5231063A (en) 1977-03-09
ZA764868B (en) 1977-07-27
NZ181865A (en) 1978-12-18
GR70296B (el) 1982-09-06
PH12363A (en) 1979-01-29
IE44533L (en) 1977-02-27
GB1563302A (en) 1980-03-26
US4083973A (en) 1978-04-11
NL7510104A (nl) 1977-03-01

Similar Documents

Publication Publication Date Title
BE845613A (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17beta de nandrolone et nouveaux esters- 17beta de nandrolone
BE849632A (fr) Composition pharmaceutique pour l'administration orale
FR2523443B1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
PH13841A (en) Pharmaceutical preparation adapted for oral administration
JPS5210415A (en) Anodyne for intraintestinal administration and its preparation
NO812224L (no) Pustedrevet anordning for administrering av pulverformige medikamenter.
DK156375C (da) Praeparater til oral administration til droevtyggere med langvarig medikamentafgivelse
BE871584A (fr) Preparations pharmaceutiques
IL53094A0 (en) New hydantoin derivatives their preparation and pharmaceutical compositions containing them
DK152333C (da) Indretning til oral indgivelse til droevtyggere
NZ182190A (en) Clavulanic acid derivatives and pharmaceutical compositions
FR2327764A1 (fr) Nouvelles compositions pharmaceutiques et leur preparation
FR2336129A1 (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
ZA763567B (en) Pharmaceutically active complexes and pharmaceutical compositions containing them
BE867919A (fr) Dispositif pour l'administration de substances medicamenteuses
AU502015B2 (en) Pharmaceutical preparations containing benzo-phenone and derivtives
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
FI792303A (fi) Farmaceutisk komposition foer rektal administration av kefalosporin
MC1372A1 (fr) Preparations pharmaceutiques
MC1371A1 (fr) Preparations pharmaceutiques
EP0004529A3 (en) Arylaminoimidazoline derivatives, their preparation, their analgetic application and pharmaceutical formulations
BE842348A (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
BE872647A (fr) Composition pharmaceutique administrable par voie orale
BE848975A (fr) Preparations pharmaceutiques contraceptive